TB Research

Prevalence, drug resistance, and genotypic diversity of the RD<sup>Rio</sup> subfamily of <i>Mycobacterium tuberculosis</i> in Ecuador: a retrospective analysis for years 2012-2016

Castro-Rodriguez B, Franco-Sotomayor G, Benitez-Medina JM, Cardenas-Franco G, Jiménez-Pizarro N, Cardenas-Franco C, Aguirre-Martinez JL, Orlando SA, et al. (10 authors)

Frontiers in public health · 2024-04

Abstract

Introduction A major sublineage within the Mycobacterium tuberculosis (MTB) LAM family characterized by a new in-frame fusion gene Rv3346c/55c was discovered in Rio de Janeiro (Brazil) in 2007, called RD Rio , associated to drug resistance. The few studies about prevalence of MTB RD Rio strains in Latin America reported values ranging from 3% in Chile to 69.8% in Venezuela, although no information is available for countries like Ecuador. Methods A total of 814 MTB isolates from years 2012 to 2016 were screened by multiplex PCR for RD Rio identification, followed by 24-loci MIRU-VNTR and spoligotyping. Results A total number of 17 MTB RD Rio strains were identified, representing an overall prevalence of 2.09% among MTB strains in Ecuador. While 10.9% of the MTB isolates included in the study were multidrug resistance (MDR), 29.4% (5/17) of the RD Rio strains were MDR. Discussion This is the first report of the prevalence of MTB RD Rio in Ecuador, where a strong association with MDR was found, but also a very low prevalence compared to other countries in Latin America. It is important to improve molecular epidemiology tools as a part of MTB surveillance programs in Latin America to track the transmission of potentially dangerous MTB stains associated to MDR TB like MTB RD Rio .

MeSH terms

  • Humans
  • Mycobacterium tuberculosis
  • Tuberculosis, Multidrug-Resistant
  • Antitubercular Agents
  • Prevalence
  • Retrospective Studies
  • Drug Resistance, Multiple, Bacterial
  • Genotype
  • Adolescent
  • Adult
  • Middle Aged
  • Ecuador
  • Female
  • Male
  • Genetic Variation